Basic Information
CorFlow Therapeutics is a medical technology start-up developing proprietary technologies for the diagnosis and treatment of microvascular obstruction in heart disease patients. The CorFlow technology enables interventional cardiologists to diagnose and treat MVO in patients with severe heart attacks, potentially reducing short- and long-term complication rates in these patients.
CorFlow Therapeutics AG
Zug,Switzerland
15~50 people
January 01, 2016
contact@corflow-therapeutics.ch

